0001493152-20-019013.txt : 20201006
0001493152-20-019013.hdr.sgml : 20201006
20201006152038
ACCESSION NUMBER: 0001493152-20-019013
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200930
FILED AS OF DATE: 20201006
DATE AS OF CHANGE: 20201006
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dickason David
CENTRAL INDEX KEY: 0001827349
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16467
FILM NUMBER: 201226612
MAIL ADDRESS:
STREET 1: 126 VALLEY ROAD
STREET 2: SUITE C
CITY: GLEN ROCK
STATE: NJ
ZIP: 07452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RespireRx Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0000849636
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330303583
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 126 VALLEY ROAD
STREET 2: SUITE C
CITY: GLEN ROCK
STATE: NJ
ZIP: 07452
BUSINESS PHONE: (201) 444-4947
MAIL ADDRESS:
STREET 1: 126 VALLEY ROAD
STREET 2: SUITE C
CITY: GLEN ROCK
STATE: NJ
ZIP: 07452
FORMER COMPANY:
FORMER CONFORMED NAME: CORTEX PHARMACEUTICALS INC/DE/
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2020-09-30
0
0000849636
RespireRx Pharmaceuticals Inc.
RSPI
0001827349
Dickason David
C/O RESPIRERX PHARMACEUTICALS INC.,
126 VALLEY ROAD, SUITE C
GLEN ROCK
NJ
07452
0
1
0
0
SVP of Pre-Clinical Prod. Dev.
Common Stock Options (to purchase shares of Common Stock)
0.0054
2020-09-30
4
A
0
2000000
0.00
A
2025-09-30
Common Stock
2000000
2000000
D
These Common Stock Options vest in four equal installments: 25 percent on December 31, 2020, 25 percent on March 31, 2021, 25 percent on June 30, 2021, and 25 percent on September 30, 2021.
/s/ David Dickason
2020-10-06